A world level of bio new drug R&D center in Daedeok Research Cluster.

Published: 2007-04-11 06:59:00

Updated: 2007-04-11 06:59:00

The Korea Institute of Toxicology (KIT) and an American bio pharmaceutical company, ISIS, planned to establish "KIT-ISIS Bio New Drug R&D Center" in attendance of Daedeok Innopolice for a successful development of bio new drugs including an anti-sense, protein new drugs and cellular therapies in the Daedeok Special Research Cluster.

Daedeok Innopolice (CEO, Park In-chul) and Korea Institute ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.